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Abstract. 
 
Exosomes are membrane vesicles secreted 
by hematopoietic cells upon fusion of late multivesicu-
lar endosomes with the plasma membrane. Dendritic 
cell (DC)-derived exosomes induce potent antitumor 
immune responses in mice, resulting in the regression 
of established tumors (Zitvogel, L., A. Regnault, A. Lo-
zier, J. Wolfers, C. Flament, D. Tenza, P. Ricciardi-Cas-
tagnoli, G. Raposo, and S. Amigorena. 1998. 
 
Nat. Med.
 
 
4:594–600). To unravel the molecular basis of exosome-
induced immune stimulation, we now analyze the regu-
lation of their production during DC maturation and 
characterize extensively their protein composition by 
peptide mass mapping. Exosomes contain several cyto-
solic proteins (including annexin II, heat shock cognate 
protein hsc73, and heteromeric G protein Gi2
 
a
 
), as 
well as different integral or peripherally associated 
membrane proteins (major histocompatiblity complex 
class II, Mac-1 integrin, CD9, milk fat globule-EGF-
factor VIII [MFG-E8]). MFG-E8, the major exosomal 
component, binds integrins expressed by DCs and mac-
rophages, suggesting that it may be involved in exo-
some targeting to these professional antigen-presenting 
cells. Another exosome component is hsc73, a cytosolic 
heat shock protein (hsp) also present in DC endocytic 
compartments. hsc73 was shown to induce antitumor 
immune responses in vivo, and therefore could be in-
volved in the exosome’s potent antitumor effects. 
Finally, exosome production is downregulated upon 
DC maturation, indicating that in vivo, exosomes are 
produced by immature DCs in peripheral tissues. Thus, 
DC-derived exosomes accumulate a deﬁned subset of 
cellular proteins reﬂecting their endosomal biogenesis 
and accounting for their biological function.
Key words: endosomes • antigen presentation • den-
dritic cells • exosomes • heat shock protein
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 term “exosome” was originally used to describe
small membrane vesicles (50–90 nm diameter) re-
leased by reticulocytes during their final stage of
maturation into red blood cells (Johnstone et al., 1987).
Exosomes eliminate plasma membrane proteins that are
not necessary for mature erythrocyte function, such as
transferrin receptor (TfR)
 
1
 
 (Pan and Johnstone, 1983;
Harding et al., 1984; Johnstone et al., 1984) or acetylcho-
line esterase (Johnstone et al., 1987). EM studies (Pan et al.,
1985) have suggested that exosomes are not formed by
budding from the plasma membrane, but that they origi-
nate from compartments of the endocytic pathway called
multivesicular bodies (MVBs). The small vesicles present
in the lumen of MVBs probably bud from the internal face
of the MVB’s limiting external membrane (Trowbridge et al.,
1993; van Deurs et al., 1993), generating vesicles with the
cytosolic face of the membrane facing the inside of the
vesicle. Upon direct fusion of MVBs with the plasma
membrane, these vesicles are released into the extracellu-
lar medium, and are then called exosomes (Pan et al.,
1985).
However, exosomes are not uniquely produced by ter-
minally differentiating reticulocytes, since Epstein-Barr vi-
rus–transformed B lymphocytes (B-EBVs) secrete similar
vesicles (Raposo et al., 1996). In B lymphocytes, as well as
in other antigen-presenting cells (APCs), compartments of
the late endocytic pathway, including MVBs, are sites
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Abbreviations used in this paper:
 
 AEP, acid-eluted peptide; APC, anti-
gen-presenting cell; B-EBV, Epstein-Barr virus–transformed B lympho-
cyte; BM, bone marrow; CLAP, chymostatin, leupeptin, aprotinin, pepsta-
tin; DC, dendritic cell; FFE, free-flow electrophoresis; gp, glycoprotein;
HDM, high density membrane; hsp, heat shock protein; Ii, invariant chain;
LDM, low density membrane; LPS, lipopolysaccharide; MALDI-TOF-MS,
matrix-assisted laser desorption ionization–time of flight mass spectrome-
try; MFG-E8, milk fat globule-EGF-factor VIII; MHC, major histocom-
patibility complex; MVB, multivesicular body; TEA, triethanolamine-acetic
acid-EDTA; TfR, transferrin receptor. 
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of peptide loading on major histocompatibility complex
(MHC) class II molecules (West et al., 1994; Morkowski
et al., 1997; Pierre and Mellman, 1998). B-EBV–derived
exosomes bear peptide–MHC class II complexes, and
present them directly to CD4
 
1
 
 T lymphocytes (Raposo
et al., 1996). Mastocytes also produce exosomes upon de-
granulation induced by a cytosolic Ca
 
11
 
 rise (Raposo et al.,
1997b), reenforcing the idea that exosomes originate from
endocytic compartments and not from the plasma mem-
brane.
More recently, we found that dendritic cells (DCs) also
secrete exosomes (Zitvogel et al., 1998). DCs are the only
APCs to induce primary and secondary immune responses
(Hart, 1997; Banchereau and Steinman, 1998). To do so
they have developed a remarkable array of specific at-
tributes. DCs exist under two maturation states: immature
DCs are efficient for antigen endocytosis and phagocyto-
sis, but inefficient for T cell activation. Cytokines, such as
tumor necrosis factor 
 
a
 
 or interleukin 1, and bacterial
compounds, such as lipopolysaccharide (LPS), induce
maturation of DCs. Mature DCs downregulate their inter-
nalization capacities but express high levels of MHC and
costimulation molecules, which makes them extremely ef-
ficient for T cell activation.
DC-derived exosomes accumulate MHC class II and
also bear MHC class I molecules. Exosomes produced by
DCs exposed to tumor-derived antigenic peptides induce
potent immune responses, such as cytotoxic T lympho-
cytes–mediated responses, leading to the regression of es-
tablished tumors in mice (Zitvogel et al., 1998). However,
the mechanisms of this spectacular antitumor effect are
still unknown.
In an attempt to understand the molecular bases of the
effects of DC-derived exosomes on the immune system,
we have determined the conditions of their production by
DCs and analyzed their protein composition. We have
identified by trypsin digestion and mass spectrometry (i.e.,
peptide mass mapping) eight major exosomal proteins.
Besides MHC class II molecules, major exosomal proteins
represent either cytosolic molecules potentially involved
in exosome formation, or membrane proteins that are
probably necessary to address exosomes to their cellular tar-
gets in vivo: a major exosomal compound is milk fat globule-
EGF-factor VIII (MFG-E8), a soluble protein binding 
 
a
 
v
 
b
 
5
and 
 
a
 
v
 
b
 
3, two integrins expressed in DCs and macrophages.
Importantly, hsc73, an efficient inducer of antitumor im-
mune responses in vivo, also accumulates in exosomes.
 
Materials and Methods
 
Cells and Antibodies
 
The spleen-derived murine DC line D1 has been described previously
(Winzler et al., 1997). It was cultured in Iscove’s modified Dulbecco’s me-
dium (Sigma Chemical Co.) supplemented with 10% endotoxin-free FCS
(Life Technologies, Inc.) and 30% R1 medium (granulocyte/macrophage
colony-stimulating factor [GM-CSF]–transfected NIH-3T3 fibroblast con-
ditioned medium). Cells were passaged twice a week in 145-mm nontissue
culture–treated petri dishes (4–5 
 
3
 
 10
 
6
 
 cells per dish). To control their
nonactivated state, the level of cell surface expression of MHC class II and
costimulatory molecules was checked regularly by FACS
 
®
 
 as described
(Winzler et al., 1997).
Fresh DCs were generated from bone marrow (BM) as described pre-
viously (Winzler et al., 1997). In brief, cells obtained from the femur BM
of C57/Bl6 mice were cultured for 2–3 wk in granulocyte/macrophage col-
ony-stimulating factor (GM-CSF)–containing medium, as described for
D1 cells.
Tumor cell line TS/A (spontaneously arising undifferentiated mam-
mary carcinoma, H-2
 
d
 
; kind gift from G. Forni, University of Turin, Turin,
Italy) was cultured in RPMI 1640 supplemented with 10% endotoxin-free
FCS, 2 mM 
 
L
 
-glutamine, 100 U/ml penicillin, 100 
 
m
 
g/ml streptomycin, non-
essential amino acids, and sodium pyruvate.
Antibodies used here were: mouse anti–I-A
 
b
 
 mAb (Y3P) for FACS
 
®
 
analysis and immunoprecipitation; rat mAb anti–mouse MHC II (M5114)
for EM; rabbit antiserum to the cytosolic sequence of mouse MHC II 
 
a
 
chain for Western blot. Rat anti–mouse invariant chain (Ii) (IN-1 mAb),
rabbit anti–mouse calnexin (kindly provided by A. Helenius, Swiss Fed-
eral Institute of Technology, Zürich, Switzerland), mouse mAb anti–
mouse annexin II (kindly provided by Dr. V. Gerke, Institut für Medi-
zinische Biochemie, Münster, Germany), rabbit anti-hsp84 (Affinity
BioReagents), and rat anti–glycoprotein (gp) 96 (SPA850) for Western
blot; rat mAb anti–mouse CD9 (PharMingen) and anti-hsc73 (SPA815)
(StressGen Biotechnologies Corp.) for Western blot, EM, and immuno-
precipitation; rat mAb anti–mouse Mac-1 (M1/70) and rabbit anti–mouse
annexin II antiserum (kindly provided by V. Gerke) for immunoprecipita-
tion and EM; and FITC-conjugated rat anti–mouse CD40 (PharMingen)
for FACS
 
®
 
 analysis.
Secondary antibodies were: FITC-conjugated anti–mouse Ig (Jackson
ImmunoResearch Laboratories, Inc.) for FACS
 
®
 
 analysis; HRP-conju-
gated secondary antibodies from Pierce for Western blotting; and poly-
clonal anti–rat antibody (DAKO), and/or protein A gold (purchased from
Dr. J.W. Slot, Department of Cell Biology, Utrecht University, The Neth-
erlands) for EM.
 
Tumor Growth Assay
 
Tumor growth assay was performed as described previously (Zitvogel et al.,
1998). In brief, BALB/c (H-2
 
d
 
) or syngeneic nude mice were injected in-
tradermally with 10
 
5
 
 TS/A cells per mouse. At day 4 after tumor inocula-
tion, mice were injected intradermally with 3–5 
 
m
 
g of exosomes per mouse
in the lower ipsilateral flank. Exosomes were prepared from 24-h superna-
tant of BALB/c bone marrow–derived DCs (BM-DCs) exposed to pep-
tides eluted from surface MHC class I molecules of tumor cells by acid
treatment (acid-eluted peptide [AEP]). As a control, AEP from normal
splenic cells were fed to BM-DCs before exosome purification. Tumor
size was monitored weekly for 1 mo.
 
Immunoelectron Microscopy
 
D1 cells, either immature or mature after treatment for 24 h with LPS,
were fixed with 2% paraformaldehyde in phosphate buffer 0.2 M, pH 7.4
(PB), for 2 h at room temperature. Ultrathin sections of cells fixed and
processed for ultracryomicrotomy (Raposo et al., 1997a), as well as whole
mounts of exosomes (Raposo et al., 1996; Escola et al., 1998), were immu-
nogold-labeled as described previously. Observations were made with a
CM120 Twin Phillips electron microscope.
 
Exosome Purification
 
Exosomes were prepared either from the supernatant of a 3-d-old DC cul-
ture, or from fresh culture medium incubated for 24 h with 3-d-old DCs.
We could not evidence any difference in the overall composition of exo-
somes purified from 3-d or from 24-h supernatants. Exosomes were puri-
fied as described previously (Raposo et al., 1996), by three successive cen-
trifugations at 300 
 
g
 
 (5 min), 1,200 
 
g
 
 (20 min), and 10,000 
 
g
 
 (30 min) to
eliminate cells and debris, followed by centrifugation for 1 h at 110,000 
 
g
 
.
The exosome pellet was washed once in a large volume of PBS, centri-
fuged at 110,000 
 
g
 
 for 1 h, and resuspended in 50–200 
 
m
 
l of PBS with
0.01% sodium azide. The amount of exosomal proteins recovered was
measured by Bradford assay (Bio-Rad).
As different batches of FCS used for tissue culture contain variable
amounts of endogenous bovine exosomes (W. Stoorvogel, personal com-
munication), the batch used for DC culture was carefully characterized in
terms of amount of bovine exosomes and markers expressed by these exo-
somes. Approximately 10% of the exosomal proteins recovered from a
D1 or BM-DC supernatant come from FCS. Two antibodies used here or
in a previous study (Zitvogel et al., 1998) recognize both murine and bo-
vine proteins present in exosomes: anti-hsc73 and anti-TfR (H68.4 hybrid-
oma). Therefore, the actual presence of the murine, DC-derived protein
in exosomes was demonstrated by immunoprecipitation from metaboli- 
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cally labeled, DC-derived exosomes (see Fig. 7), and by Western blots
performed on exosomes produced by DCs grown in medium depleted of
bovine exosomes by overnight centrifugation at 110,000 
 
g
 
 (data not
shown). Under these conditions, TfR was detected but not enriched in ex-
osomal preparations (data not shown).
Flotation of exosomes on a continuous sucrose gradient was performed as
described (Raposo et al., 1996), but in an SW41 rotor. Fractions of the gradi-
ent (1 ml each) were diluted in 2 ml of PBS, centrifuged for 1 h at 100,000 
 
g
 
,
and the pellet was loaded on a 10% SDS gel for Western blot analysis.
 
Protein Analysis by SDS-PAGE and Western Blots
 
Total proteins were obtained from D1 cells lysed in 50 mM Tris, pH 7.5,
0.3 M NaCl, 0.5% Triton X-100, 0.1% sodium azide, with a cocktail of an-
tiproteases (chymostatin, leupeptin, aprotinin, pepstatin [CLAP], 100 
 
m
 
M
each; Sigma Chemical Co.), and cleared from nuclei by centrifugation at
10,000 
 
g
 
. To separate cytosol and total membranes, D1 cells were homog-
enized in 10 mM triethanolamine, 1 mM EDTA, 10 mM acetic acid, 250 mM
sucrose, pH 7.4 (TEA-sucrose), supplemented with CLAP, by 60 passages
through a 25-G needle. The supernatant, cleared from nuclei and cell de-
bris by centrifugation at 1,200 
 
g
 
, was centrifuged for 1 h at 100,000 
 
g
 
; total
membranes were recovered in the pellet and cytosol in the supernatant.
Proteins (1–10 
 
m
 
g) were separated on 10 or 12% SDS-PAGE, blotted
on Immobilon (Millipore), and detected by Western blot using an en-
hanced chemiluminescence detection kit (Boehringer Mannheim).
 
Metabolic Labeling of Cells and Exosomes
 
Metabolic labeling of D1 cells or BM-DCs was performed: cells were
starved for 1 h at 37
 
8
 
C in methionine/cysteine-free RPMI supplemented
with 30% dialyzed R1 medium (labeling medium), and incubated over-
night at 37
 
8
 
C in fresh labeling medium supplemented with 5% FCS and
10–20 
 
m
 
Ci/ml [
 
35
 
S]methionine/cysteine (Promix 
 
35
 
S; ICN). Labeling me-
dium was removed, then cells were washed and further incubated for 24 h
in complete medium at 37
 
8
 
C. Exosomes were purified from the superna-
tant; total lysates, cytosol, and total membranes were prepared from the
same cells. Proteins (20,000 cpm of each sample) were separated on a 12%
SDS-PAGE, dried, and autoradiographed. The peak profile of each lane
was obtained using NIH Image software. Alternatively, 200,000 cpm of
exosomes were loaded on a continuous sucrose gradient. The fractions
were then run on a 10% SDS-PAGE, dried, and autoradiographed. For
immunoprecipitation, 3 
 
3
 
 10
 
6
 
 cpms of cell lysates or exosomes were di-
luted in 1 ml lysis buffer, precleared for 2 h in the presence of 50 
 
m
 
l pro-
tein G–Sepharose, and precipitated with specific antibodies coated on
protein G–Sepharose.
 
Protein Analysis by Matrix-assisted Laser Desorption 
Ionization–Time of Flight Mass Spectrometry
 
30 
 
m
 
g of proteins from exosomes or total lysates was run on an 8–15%
SDS-PAGE and stained with Coomassie blue (Bio-Rad). The major bands
in the exosomes preparation were excised from the gel, and in-gel di-
gested with trypsin as described previously (Rabilloud et al., 1998). An al-
iquot of the digest solution was analyzed by matrix-assisted laser desorp-
tion ionization–time of flight mass spectrometry (MALDI-TOF-MS),
using a Bruker Biflex mass spectrometer (Bruker-Franzen Analytik)
equipped with a scout multiprobe inlet and a gridless delayed extraction
ion source. Ion acceleration voltage was 19.5 kV and the reflectron volt-
age was 20.0 kV. For delayed ion extraction, a 6.2-kV potential difference
between the probe and the extraction lens was applied. Mass spectra of
peptide mixtures were acquired as the sum of ion signals generated by ir-
radiation of the target with 100 laser pulses. They were calibrated using
ion signals from trypsin autodigestion peptides (MH
 
1
 
 842.50, MH
 
1
 
1045.55, and MH
 
1
 
 2211.09). Monoisotopic peptide masses were assigned
and used in database searches. Typical search parameters, using the Mi-
crosoft FIT program, were as follows: maximum allowed peptide mass er-
ror of 100 ppm; consideration of one incomplete cleavage per peptide; no
restriction was placed on the isoelectric point of the protein, and a protein
mass range of 0–200 kD was allowed.
 
Subcellular Fractionation
 
Subcellular fractionation of D1 cells was performed as described previ-
ously for murine B lymphoma cells (Amigorena et al., 1994). In brief, cells
homogenized in TEA-sucrose were first fractionated on a discontinuous
sucrose gradient, where the low density membrane (LDM) fraction was
recovered at the junction between 1 and 0.25 M sucrose, and the high den-
sity membrane (HDM) fraction at the junction between 1.04 and 1 M su-
crose. After mild trypsin digestion (5 ng trypsin [Sigma Chemical Co.] per
 
m
 
g of proteins, 10 min at 37
 
8
 
C, stopped by soybean trypsin inhibitor, 10
ng/ng trypsin), LDMs were loaded on a free-flow electrophoresis (FFE)
chamber (Dr. Weber, GmbH, Ismaning, Germany). Fractions were col-
lected, pooled pairwise, and analyzed for protein content (Bradford assay;
Bio-Rad) and 
 
b
 
-hexosaminidase activity (Green et al., 1987). 15 pools of
fractions, within 10 fractions of the protein and 
 
b
 
-hexosaminidase activity
peaks, were kept for further analysis. They were centrifuged at 10,000 
 
g
 
for 1 h, and the pellets were resuspended in reducing SDS sample buffer
and run on SDS-PAGE for Western blot analysis.
Figure 1. In vivo effects of BM-DC–derived exosomes. Immuno-
competent (A) or nude (B) mice bearing 4-d-old TS/A mammary
tumors were injected intradermally with exosomes (5 mg/mouse)
produced by BM-DCs pulsed with AEP (i.e., MHC-associated
peptides) from either TS/A tumor cells (DC ex-TS/A AEP) or
splenic cells (DC ex-Spleen AEP). Tumor size was monitored
weekly. Tumor growth was significantly delayed in tumor-AEP
exosome–injected mice, compared with splenic-AEP exosome–
or saline-injected mice (A). In nude mice lacking T lymphocytes,
TS/A tumor growth was not affected by the same treatments (B).
Each experimental group included five mice. Experiments were
reproduced twice with similar results. Asterisks represent signifi-
cant results at 95% using Fisher’s exact method compared with
injection of saline. 
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Results
 
DC-derived Exosomes Elicit Antitumor Immune 
Responses In Vivo
 
We have recently shown that murine BM-DCs secrete ex-
osomes (Zitvogel et al., 1998). Exosomes were purified by
ultracentrifugation from supernatants of BM-DCs ex-
posed to peptides eluted from MHC class I molecules at
the surface of a tumor cell line. Injection of tumor peptide-
pulsed exosomes into mice bearing the tumor induced a
strong delay in tumor growth, whereas injection of exo-
somes pulsed with normal spleen–eluted peptides had no
Figure 2. Immunoelectron
microscopy of D1 cells and
exosomes. Ultrathin cryosec-
tions of immature (A) and
mature (B) D1 cells were sin-
gle immunogold-labeled with
the rat anti–MHC class II
mAb M5114 as described in
Materials and Methods. (A)
Immature D1 cells show nu-
merous MHC class II–posi-
tive compartments with in-
traluminal vesicles. MHC
class II are also detected at
the plasma membrane (pm).
(Insert) Whole-mounted exo-
somes immunogold-labeled
with M5114. (B) In mature
D1 cells (24 h in the presence
of LPS), the plasma mem-
brane (pm) shows numerous
processes and is intensely la-
beled with the M5114 anti-
body. Very few intracellu-
lar compartments containing
MHC class II molecules are
observed. n, nucleus. Bars,
200 nm. 
Théry et al. 
 
Protein Composition of Exosomes from Dendritic Cells
 
603
 
effect (Fig. 1 A) (Zitvogel et al., 1998). This antitumor re-
sponse was only observed in immunocompetent mice; in
nude mice that lack T lymphocytes, tumor growth was not
affected by injection of exosomes pulsed with tumor pep-
tides (Fig. 1 B). Therefore, DC-derived exosomes elicit T
cell–dependent immune responses resulting in reduced tu-
mor growth and tumor eradication (Zitvogel et al., 1998).
 
The D1 DC Line as a Model System for
Studying DC-derived Exosomes
 
To unravel the molecular mechanisms of exosome action,
we used the well-characterized growth factor–dependent
murine spleen DC line, D1 (Winzler et al., 1997). D1 cells
show all the attributes of fresh immature DCs, including
high endocytic capacity and abundant MHC class II–con-
taining lysosomal compartments.
As shown by EM, immature D1 cells displayed numer-
ous characteristic MVBs containing internal vesicles la-
beled by anti–MHC class II antibodies (Fig. 2 A). Such
MVBs were also observed apposed or in close proximity
to the cell surface, suggesting their possible fusion with the
plasma membrane and the secretion of exosomes. Exo-
somes were indeed isolated from D1 culture supernatants
by differential centrifugation as described previously (Ra-
poso et al., 1996). After the last ultracentrifugation step,
the pellet was washed once in PBS. Thus, we obtained rou-
tinely 15–20 
 
m
 
g of exosomal proteins (as measured by
Bradford assay) from the supernatant of a 24-h culture of
2 
 
3
 
 10
 
7
 
 immature D1 cells.
Whole-mount EM preparations of exosomes showed a
population of vesicles (Fig. 2 A, insert), similar in size and
morphology to BM-DC–derived exosomes (Zitvogel et al.,
1998). As noted above for DC-derived exosomes, these
vesicles are more heterogeneous in size and MHC class II
labeling than B-EBV–derived exosomes (40–90 vs. 50–80
nm in diameter, respectively). Western blot analysis (Fig. 3
A) showed that exosomes secreted by D1 cells are, like ex-
osomes produced by B-EBV or by BM-DCs (Raposo et al.,
1996; Zitvogel et al., 1998), enriched in MHC class II, and
devoid of Ii, which associates with newly synthesized
MHC class II in the ER. D1-derived exosomes are also de-
void of calnexin (an ER resident protein). Like exosomes
from B-EBV cells (Raposo et al., 1996), D1-derived exo-
somes migrate on a continuous sucrose gradient at a den-
sity of 1.14–1.20 g/ml (Fig. 3 B), confirming their vesicular
nature.
Therefore, exosomes produced by D1 cells resemble ex-
osomes produced by BM-DCs or B-EBVs. We decided to
use D1 cells to analyze the regulation of exosome produc-
tion during DC maturation and to characterize the molec-
ular composition of exosomes.
 
Exosome Production during DC Maturation
 
In immature DCs, most MHC class II and Ii molecules are
found in late endocytic compartments (Cella et al., 1997;
Pierre et al., 1997). As shown in Fig. 2 A, many of these
compartments display intraluminal membrane vesicles.
Upon maturation, these compartments disappear, and
MHC class II molecules are redistributed to the plasma
membrane (Cella et al., 1997; Pierre et al., 1997). Accord-
ingly, we observed that after LPS treatment of D1 cells for
24 h, the number of MHC class II–positive compartments,
as well as the amount of MHC class II in the remaining
compartments, decreased (on average, the number of
MVBs per cell profile decreased from five to eight in im-
mature, to one to two in mature D1 cells) (Fig. 2 B). Con-
comitantly, MHC class II labeling at the cell surface is
highly increased, and the plasma membrane displayed nu-
merous processes (Fig. 2 B, pm). Although the precise
pathway of MHC class II transport to the plasma mem-
brane during this maturation process is still unknown, it is
possible that direct fusion of endocytic compartments with
the plasma membrane participates in this process. In this
case, increased exosome production should occur upon
DC maturation.
We tested this possibility by quantifying the amount of
exosomal proteins produced by immature D1 cell in the
presence or absence of LPS. Unexpectedly, we observed a
lower production of exosomes in the presence of LPS (a
35% reduction) (Fig. 4 A, LPS 24h). Furthermore, if matu-
ration was induced for 16 h, before the 24-h time period of
exosome collection, the amount of produced exosomes
was reduced by 67%, as compared with immature D1 cells
(Fig. 4 A, LPS 40h). At the end of the total 40-h LPS treat-
ment, D1 cells showed all the signs of maturation: in-
creased surface expression of MHC class II and costimula-
tory molecules, and decreased internalization activity (Fig.
4 B). Similar results were obtained with murine BM-DCs
and with human monocyte–derived DCs (data not shown).
Figure 3. Western blot analysis of MHC class II, Ii, and calnexin
in whole D1 cells and exosomes. (A) 10, 3, or 1 mg of proteins
from whole cell lysate (Cells) or exosomes (Exos) was loaded on
a 12% SDS gel followed by Western blotting using antibodies
against MHC class II molecules (MHC II), Ii, and calnexin (Cal-
nex). MHC class II are enriched in exosomes compared with
whole cells, whereas Ii and calnexin are absent from exosomes.
(B) 90 mg of exosomes was loaded on a continuous sucrose gradi-
ent (0.25–2 M sucrose, resulting in densities ranging 1–1.5 g/ml),
and the fractions were analyzed by Western blot using the anti–
MHC class II antibody. Exosome-associated MHC class II mole-
cules float at an average density of 1.14 g/ml. 
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Therefore, production of exosomes is developmentally
regulated: it is effective in immature DCs and reduced
upon maturation, when endocytic activity of DCs de-
creases. These results also suggest that exosome formation
is an active process, requiring the selection of a limited set
of proteins, whose identity defines exosomes as an inde-
pendent cellular compartment and whose functions deter-
mine their biological roles.
 
Overall Protein Composition of Exosomes: A Few 
Proteins Selectively Accumulate in Exosomes
 
Therefore, we undertook an extensive characterization of
the protein composition of exosomes. D1 cells were meta-
bolically labeled overnight with [
 
35
 
S]methionine/cysteine,
washed once, and fresh nonradioactive medium was added
to the cells for 24 h. Metabolically labeled exosomes were
purified from this supernatant. In four independent exper-
iments, the amount of radioactivity recovered in exosomes
was 0.17 
 
6 
 
0.1% of the radioactivity incorporated into
cells.
The protein composition of exosomes from metaboli-
cally labeled cells was analyzed by SDS-PAGE and auto-
radiography, and compared with that of whole D1 cells,
cytosol, or total cellular membranes. As shown in Fig. 5
A, exosomes displayed a unique protein composition pat-
tern. At least seven proteins (of 
 
z
 
180, 90, 70, 58, 43, 32,
and 27 kD) (see dots in “exos” panel of Fig. 5 A) were
strongly enriched in exosome preparations compared
with whole cells, cytosol, or total membranes. At least
eight other major proteins from whole cells, cytosol, or to-
tal membranes were either absent or less abundant in ex-
osomes (see stars in “cells” panel of Fig. 5 A). Interest-
ingly, two of the bands enriched in exosomes (70 and 58
kD) are not detected in the cytosol or in the cell lysates,
suggesting a particularly strong mechanism of enrichment
of this protein in exosomes. Similar analyses were per-
formed on metabolically labeled primary BM-DCs, and
the pattern of bands obtained was very similar to that of
exosomes from D1 cells (data not shown). All the pro-
teins present in exosomes comigrated on a continuous
sucrose gradient at the expected density (1.15 g/ml),
confirming that all the proteins in the exosome pellets
are associated to vesicular structures of similar density.
Therefore, DC-derived exosomes accumulate a unique
subset of cellular proteins.
To identify these proteins, 30 
 
m
 
g of exosomes was
loaded on an 8–15% gradient SDS gel; the pattern of
bands stained by Coomassie brilliant blue was very similar
to that of metabolically labeled exosomes (Fig. 6). All of
these major bands (Fig. 6, bands 1–11) were excised,
trypsin-digested, and the peptides generated were ana-
lyzed by MALDI-TOF-MS. The peptide profiles gener-
ated from the different bands were compared with the the-
oretical tryptic peptide profiles of known proteins from
the databases (Jensen et al., 1996). The results are summa-
rized in Table I. Among the identified proteins, three are
transmembrane (Mac-1 
 
a
 
 chain, MHC II 
 
b
 
 chain, and
CD9), one is secreted and peripherally associated to mem-
branes (MFG-E8), and four are cytosolic, often found in
association with membranes (Gi2
 
a
 
, annexin II, gag from
MRV provirus, and hsc73).
In two cases (MFG-E8 and gag), the theoretical molecu-
lar weight of the identified protein was not consistent with
its migration on the SDS gel. Two forms of MFG-E8, due
to various degrees of glycosylation, have been described in
mice and cows (Stubbs et al., 1990; Aoki et al., 1995;
Hvarregaard et al., 1996), probably accounting for the mi-
gration of MFG-E8 as three separate bands in our exo-
some preparation (Fig. 6 and Table I). Gag is first trans-
lated as a 60-kD precursor and subsequently cleaved into
Figure 4. Exosomes production by D1 cells upon maturation.
(A) Exosomes were purified from a 24-h supernatant of D1 cells
in control culture medium (control), or in the presence of 20
mg/ml LPS (LPS 24h), or in the presence of LPS and after a 16-h
pretreatment with LPS (LPS 40h). The same number of D1 cells
was used in each condition. Exosome production in the presence
of LPS, as quantified by the Bradford assay, was rapported to the
production by control cells. This graph represents the average of
seven (LPS 24h) or two (LPS 40h) independent experiments.
LPS treatment reduces the production of exosomes by D1 cells.
(B) D1 cells in control conditions (Cont) or after 40 h in the pres-
ence of LPS (LPS 40h) were analyzed by FACS® after staining
with antibodies specific for MHC class II molecules (MHC II)
and CD40 (grey histograms; white histograms are negative con-
trols obtained without primary antibodies), or after 15 min inter-
nalization at 378C of FITC-coupled 40,000-Dalton dextran (DX-
FITC) (grey histogram; white histogram is a negative control ob-
tained after 15 min internalization at 48C). As expected from ma-
ture D1 cells, both MHC class II and CD40 are upregulated at
the surface of LPS-treated cells, whereas their endocytosis ability
(as measured by the capacity to internalize dextran) is reduced
compared with control cells. 
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three mature products: the gag peptides generated from
band 10 all matched the mature 30-kD core shell protein.
The presence of hsc73, annexin II, MHC II, Mac-1, and
CD9 in exosomes from D1 cells and primary BM-DCs was
quantified by Western blot and immunoprecipitation from
metabolically labeled cells (Fig. 7, A and B). Similar
amounts of exosomes and cell lysates (2 and 6 
 
m
 
g) or the
same number of counts (3 
 
3
 
 10
 
6
 
 cpm) were analyzed by
Western blot and immunoprecipitation, respectively. MHC
II and CD9 were highly enriched (
 
.
 
10-fold) in exosomes
compared with total cells. Mac-1 was enriched by 5–10-
fold, annexin II and hsc 73 by 2–3-fold. These results con-
firm the MALDI-TOF-MS analysis and show that exo-
somes accumulate a defined set of cellular proteins.
Immunoelectron microscopy analysis (Fig. 7 C) of
whole-mounted exosomes showed staining for MHC II,
CD9, and Mac-1, but not for annexin II and hsc73, al-
though the antibodies used stained D1 cells ultrathin cryo-
sections (data not shown). These results suggest that in
contrast to MHC class II, CD9, and Mac-1, hsc73 and an-
nexin II are not exposed at the surface of exosomes but
contained within their lumen.
 
Selective Accumulation of hsc73 in Exosomes and 
Endocytic Compartments
 
The MALDI-TOF-MS analysis of band 4 revealed a mix-
ture of the MFG-E8 protein and another protein of poten-
tial interest in our study of exosome-mediated antitumor
effects: the 70–kD hsp family member, hsc73. Several
groups have reported that three hsp family members,
hsc73, gp96, and hsp84, induce immune responses and re-
jection of established tumors (Ullrich et al., 1986; Arnold
et al., 1995; Nicchitta, 1998; Srivastava et al., 1998). Since
the presence of hsc73 in exosomes could be relevant for
exosome’s antitumor effects, we analyzed in more detail
the presence of different hsp family members in DC-
derived exosomes.
As shown in Figs. 7 A and 8 A, when the same amount
Figure 5. Overall protein composition of metabolically labeled
exosomes and D1 cells. (A) Exosomes purified from the superna-
tant of metabolically labeled D1 cells were run on a 12% SDS gel
(exos), together with lysate (including both cytosolic and mem-
brane components) obtained from the whole cells (cells), cytosol
(cyto), or total membranes (mb) prepared from the same cells in
the absence of detergent. The dried gel was autoradiographed for
24 h (proteins .45 kD) or 48 h (proteins ,45 kD). A pic profile
of each lane was obtained with the NIH Image software. Stars
point to proteins abundant in the cells and absent in exosomes,
dots to proteins enriched in exosomes. (B) Metabolically labeled
exosomes were subjected to flotation on a continuous sucrose
gradient. The fractions were collected (density 1.08–1.28 g/ml),
run on a 10% SDS-PAGE, and compared with exosomes that
had not been subjected to flotation (Ex). All the proteins present
in exosomes comigrate at the expected density (1.15 g/ml) (see Fig.
2 B; Raposo et al., 1996).
Figure 6. Protein profile of D1 exo-
somes as seen by Coomassie blue
staining. 30 mg of exosomes was
separated on an 8–15% gradient
SDS gel and stained with Coo-
massie brilliant blue. The band pat-
tern is similar to that obtained with
metabolically labeled exosomes.
The major bands (1–11) were ana-
lyzed by trypsin digestion and
MALDI-TOF-MS (see Table I). 
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of proteins from total cells or from exosomes were ana-
lyzed by Western blot, approximately three times more
hsc73 could be detected in the exosomal preparations than
in D1 total cell lysates. The two other main hsps generat-
ing antitumor immune responses (Srivastava et al., 1998)
were either absent (gp96), or present, but not enriched
(hsp84) in exosomes, compared with cell lysates (Fig. 8 A).
In murine fibroblasts, hsc73, or a closely related protein,
accumulates in lysosomes (Agarraberes et al., 1997), rais-
ing the possibility that the presence of hsc73 in exosomes
results from its selective accumulation in endocytic com-
partments. Therefore, we analyzed the subcellular distri-
bution of the three main hsps involved in antitumor immu-
nity, gp96, hsp84, and hsc73. Subcellular fractionation of
D1 cells was performed first by discontinuous sucrose flo-
tation to separate cytosol and HDMs (ER, some plasma
membrane, and Golgi apparatus) from LDMs (endosomes,
lysosomes, plasma membrane, and Golgi apparatus). The
LDMs were then further fractionated by FFE, to separate
endosomes and lysosomes from the other cell membranes
(Marsh et al., 1987).
As expected, gp96 was found in the HDMs and LDMs,
but was absent from the cytosol (Fig. 8 B). In contrast,
hsp84 was detected in the cytosol and the HDMs (which,
because of the setting of the sucrose gradient, is often
contaminated with cytosol), but totally absent from the
LDMs. hsc73 was present in all three fractions, consistent
with its proposed presence in the cytosol and endocytic
pathway. Before the FFE, LDMs were mildly trypsin di-
gested. This treatment generated a 60-kD tryptic fragment
of hsc73, and a 80-kD fragment of gp96 (Fig. 8, B and C,
right panel).
The LDMs were then further fractionated by FFE. Most
cellular membranes are not negatively charged, and conse-
quently, the bulk of cellular proteins are not shifted to the
anode (Fig. 8 C, Bradford curve). Negatively charged en-
dosomal and lysosomal membranes, as detected by 
 
b
 
-hex-
osaminidase enzymatic activity (a lysosomal resident en-
zyme), were found in the fractions deviated towards the
anode (Fig. 8 C, 
 
b
 
-Hex curve). Western blot analysis of
the FFE fractions, using anti–MHC class II antibodies,
showed that in D1 cells, as in human and mouse DCs
(Cella et al., 1997; Pierre et al., 1997), abundant MHC
class II molecules are present in the endocytic pathway
(Fig. 8 C).
To localize hsc73 and gp96 in the fractions, the same fil-
ters were hybridized with the corresponding specific anti-
bodies. As expected, gp96 was only present in unshifted
FFE fractions, containing plasma, ER, and Golgi mem-
branes. In contrast, most hsc73 was found in shifted FFE
fractions, together with endosomes and lysosomes (Fig. 8
C). Therefore, hsc73 accumulates in endocytic compart-
ments in D1 cells, probably accounting for the selective
presence of hsc73 in exosomes.
 
Discussion
 
DC-derived exosomes elicit potent T cell–dependent im-
mune responses in mice (Zitvogel et al., 1998). This strik-
ing effect on the immune system in vivo prompted us to
analyze the molecular structure of exosomes. Thus, here
we identify eight major proteins from DC-derived exo-
somes. Fig. 9 shows a scheme of our current idea of the na-
ture and topology of the major proteins present in exo-
somes. Exosomes contain a defined subset of cytosolic
proteins, most likely involved in exosome function and/or
biogenesis (Fig. 9, hsc73, annexin II, Gi2
 
a
 
). Exosomes also
accumulate membrane proteins potentially involved in
their association to target cells (Fig. 9, MFG-E8, Mac-1,
CD9) or in T cell activation (Fig. 9, MHC class I and II,
B7.2). The most abundant exosomal protein, MFG-E8,
binds to integrins (
 
a
 
v
 
b
 
3 and 
 
a
 
v
 
b
 
5) expressed in DCs and
macrophages, and could target DC-derived exosomes to
other APCs. Another exosomal protein, the hsp 70 family
member hsc73, is a potent inducer of antitumor immune
responses in vivo, suggesting a mechanism for exosome’s
antitumor effects (Zitvogel et al., 1998).
The presence of hsc73 in exosomes is interesting in rela-
tion to two aspects of exosome biology: their biogenesis
and their biological effects in vivo. We show that in D1
 
Table I. Analysis of the Tryptic Peptide Profiles of 11 Major Exosomal Proteins by MALDI-TOF-MS
 
Band*
Total no.
of peptides
 
‡
 
Protein identified (NCBI accession no.)
Matching
peptides
 
§
 
Estimated protein
molecular mass
 
¶
 
Percentage of the
protein covered
 
kD %
 
1 15 Mac-1 
 
a
 
 chain (X07640) 11 127.5 12
2 20 n.i.
3 19 mP47 
 
5
 
 MFG-E8 (Y11684) 11 45 24
4 28 hsc73 (U73744) 1 11 70.9 20
mP47 5 MFG-E8 (Y11684) 10 45 23
5 15 mP47 5 MFG-E8 (Y11684) 12 45 29
6 7 actin (M12481) 7 41.7 20
7 11 G protein Gi2a subunit (P08752) 9 40.1 32
8 9 calpactin I heavy chain 5 annexin II (M14044) 7 38.7 24
9 9 MRV provirus gag (core shell protein p30) (S80082) 1 4 60.4 16
MHC II b chain (P14483) 4 30.1 22
10 9 CD9 (P40240) 1 nonidentified 4 25.2 11
11 10 nonidentified
*Band numbers correspond to numbers in Fig. 6.
‡Total number of peptides used for comparison with the databases.
§Number of peptides matching the identified protein.
¶Molecular mass estimated from the amino acid sequence.Théry et al. Protein Composition of Exosomes from Dendritic Cells 607
cells, a significant fraction of hsc73 is associated to en-
docytic compartments (see Fig. 8 B), as suggested in other
cell types such as fibroblasts (Agarraberes et al., 1997).
Furthermore, the two other hsps analyzed here, gp96 (also
known as grp94) and hsp84 (or hsp90), are not associated
to endosomes and lysosomes (Fig. 8, B and C), and do not
accumulate in exosomes (Fig. 8 A). These results are con-
sistent with the idea that exosomes form in endocytic com-
partments.
The topography of exosome-associated hsc73 is unclear.
As a cytosolic protein, hsc73 should be inside the vesicles.
Consistent with this possibility, exosome-associated hsc73
was partially protected from trypsin digestion (data not
shown), and was not detected by immunoelectron micros-
copy on whole mounts of exosomes (Fig. 7), suggesting
that it resides inside exosomes. However, hsc73 may also
be taken up by a putative specific receptor (Arnold-Schild
et al., 1999) and accumulate on MVB internal vesicles, and
thereby on the surface of exosomes. Dice and co-workers
have shown that hsc73 is involved in binding misfolded
proteins and addressing them to lysosomes, suggesting
that hsc73 may translocate across lysosomal membranes
(Cuervo et al., 1995; Hayes and Dice, 1996). Moreover, in
exosomes secreted by reticulocytes, the two major pro-
teins (on Coomassie blue–stained gels) are TfR and hsc73
(Davis et al., 1986): hsc73 was postulated to associate with
the TfR in order to help its segregation into exosomes.
However, hsc73 in exosomes from DCs may play a totally
different role.
The presence of hsc73 in exosomes of APCs is most in-
teresting in the light of results showing that hsps induce
antitumor immune responses (Srivastava et al., 1998).
hsc73 is associated with endogenous peptides, and injec-
tion of hsc73 purified from the tumor in tumor-bearing
mice stimulates potent cytotoxic T lymphocyte immune
responses and tumor rejection (Udono and Srivastava,
1993). Furthermore, hsc73-associated peptides are effi-
ciently transferred to APCs for MHC class I and II antigen
presentation (Udono and Srivastava, 1994; Blachere et al.,
1997). This may be due to the presence of a receptor for
hsc73 at the surface of macrophages and DCs (Arnold-
Schild et al., 1999). hsc73 can also induce macrophages to
activate T cells independently of antigen (Breloer et al.,
1999). The role of exosomes in peptide transfer between
cells and their capacity to activate macrophages and DCs
are under examination.
Indeed, it is still unclear whether exosomes interact di-
rectly with T lymphocytes or require the presence of an
additional APC. Although direct stimulation of T cells by
exosomes was observed in several antigenic systems in
vitro (Raposo et al., 1996; Zitvogel et al., 1998), it was al-
ways inefficient, compared with stimulation induced by in-
tact APCs. In contrast, our recent results show that T cell
stimulation by exosomes is much more efficient in the
presence of DCs (Regnault, A., A. Lozier, C. Théry, G. Ra-
poso, S. Amigorena, and L. Zitvogel, manuscript in prepa-
ration), suggesting an indirect mode of action for exosomes
in vivo. In any case, to induce immune responses, exosomes
must interact with target cells: T lymphocytes or APCs.
From this point of view, the strong enrichment of MFG-
E8 in exosomes is very interesting. MFG-E8 was originally
described at the surface of milk fat globules (Stubbs et al.,
1990; Larocca et al., 1991; Hvarregaard et al., 1996). It has
two EGF-like domains, with an integrin-binding, Arg-Gly-
Asp motif and a phosphatidylserine-binding, factor VIII–
like, domain. Our preliminary results show that exosomal
membranes expose phosphatidylserine (Théry, C., B. Hu-
gel, and J.-M. Freyssinet, unpublished data), suggesting
that MFG-E8 may bind exosomes through phospholipids.
The human and bovine homologues of MFG-E8 also in-
teract with avb3 and avb5 integrins (Andersen et al., 1997;
Taylor et al., 1997). Interestingly, avb3 and avb5 are ex-
Figure 7. Analysis of five of the identified proteins in D1- and
fresh BM-DC–derived exosomes. (A) 6 and 2 mg of proteins from
whole cells (Cells) or exosomes (Exos) was separated on a 10%
SDS gel and analyzed by Western blot using antibodies specific
for annexin II, MHC II, CD9, and hsc73. (B) 3 3 106 cpm from
metabolically labeled D1 cells (Cell) or exosomes (Ex) were im-
munoprecipitated with antibodies specific for annexin II, MHC
II, CD9, hsc73, and Mac-1 (Ab), or with the corresponding iso-
type-matched control antibodies (neg). Immunoprecipitates were
run on 10 or 8% SDS gels and autoradiographed for 1 mo (the
gel corresponding to hsc73 was only exposed for 1 wk to better
distinguish hsc73 from a nonspecific band that also precipitates in
cell lysates, but not exosomes, with protein G alone). (C) Immu-
noelectron microscopy was performed on whole-mounted D1-
derived exosomes. Due to the small size of exosomes and the po-
tentially low number of molecules on each vesicle, not all vesicles
are positive for each antibody. However, exosomes are distinctly
positive for MHC II, CD9, and Mac-1. hsc73 and annexin II, on
the other hand, are not detected in these preparations, suggesting
that they are either present at a level below the detection thresh-
old of the technique or not accessible to antibodies, i.e., con-
tained within the lumen of exosomes.The Journal of Cell Biology, Volume 147, 1999 608
pressed at the surface of macrophages and immature DCs,
respectively, and mediate the phagocytosis of apoptotic
bodies for clearance (Fadok et al., 1992) or for antigen
presentation by MHC class I molecules (Albert et al.,
1998). Therefore, MFG-E8 may target DC-derived exo-
somes to other APCs rather than to T lymphocytes.
Furthermore, several other major exosome components
could be involved in exosome–T cell or exosome–APC in-
teraction. The presence and abundance of several mem-
bers of the tetraspan protein family (CD63, CD81, CD82)
in exosomes of B-EBVs or DCs have been reported re-
cently (Escola et al., 1998; Zitvogel et al., 1998). CD63 and
CD82 interact with several membrane proteins, including
integrins and MHC class I and II molecules, and probably
potentiate cell–cell interactions (Hammond et al., 1998;
Porter and Hogg, 1998). We show here that another tet-
raspan family member, CD9, is most likely the major tet-
raspan in DC-derived exosomes (see Table I). CD9 also
associates to other transmembrane proteins, and is a co-
factor potentiating the interaction of an EGF-like growth
factor and its receptor (Higashiyama et al., 1995; Naka-
mura et al., 1995; Indig et al., 1997; Rubinstein et al., 1997).
Therefore, CD9 could participate in the interaction of exo-
somes with either APCs or T cells in vivo.
Another component of exosomes potentially involved in
their interaction with cells is the a chain of Mac-1 (a b2 in-
tegrin also known as the type 3 complement receptor,
CR3) (Gahmberg et al., 1997). Since we have coprecipi-
tated this chain with its b chain counterpart from exo-
somes (Fig. 7), it is likely that functional Mac-1 is present
at the surface of exosomes. Observations made by EM us-
ing an anti–Mac-1 antibody on preparations of intact exo-
somes as well as the known orientation of MHC class II
molecules at the surface of B-EBV– or DC-derived exo-
somes (Raposo et al., 1996, 1997c), suggest that Mac-1 is
present at the surface of exosomes in a conformation suit-
able for binding to its ligands. Therefore, Mac-1–express-
ing exosomes could be addressed to ICAM-1– or ICAM-
2–expressing cells (the known ligands for Mac-1) such as
DCs, lymphocytes, or endothelial cells.
The presence in exosomes of plasma membrane–associ-
ated proteins, such as Mac-1 or CD9, could be explained
by the extremely high constitutive internalization rate (in-
cluding endocytosis and macropinocytosis) in immature
DCs (Sallusto et al., 1995). As a result, most plasma mem-
brane proteins are actively internalized and continuously
recycled. This property may be important for the genera-
tion of exosomes, since mature DCs, with reduced inter-
nalization abilities, produce less exosomes than immature
DCs (Fig. 4).
Concerning the cytosolic proteins found in exosomes, all
of them are involved in vesicle budding or fusion of intra-
cellular compartments. Annexin II plays a role in early en-
dosome fusion, and in fusion of secretion granule with the
plasma membrane (Chasserot-Golaz et al., 1996; Liu et al.,
1996). The Gi2a subunit of heterotrimeric G proteins has
been found in phagosomes (Garin, J., unpublished obser-
vations), but its role is still unclear. The eventual presence
in exosomes of the b and g subunits, which normally asso-
ciate with Gia, will be tested.
Finally, detection of a murine retrovirus gag protein in
exosomes may reflect the presence of endogenous retrovi-
Figure 8. Analysis of the
hsps73, hsp84, and gp96 in D1
cells and exosomes. (A) 2 mg
of proteins from whole cells
(Cells) or exosomes (Exos)
was analyzed by Western blot
using antibodies against the
90-kD hsp family members
gp96 and hsp84, or against
hsc73 and MHC class II. Only
hsc73 is enriched in exo-
somes. (B) D1 cells were frac-
tionated on a discontinuous
sucrose gradient to obtain an
HDM fraction containing
ER, Golgi, and plasma mem-
branes, and an LDM fraction
containing most endosomal
and lysosomal membranes as
well as ER, Golgi, and plasma
membranes. These mem-
branes and cytosol were ana-
lyzed by Western blot using
antibodies against gp96,
hsp84, hsc73, and MHC class II. (C) After mild trypsin digestion, LDMs were fractionated by FFE to separate negatively charged endo-
somes and lysosomes from the ER, Golgi, and plasma membranes (Marsh et al., 1987). Protein concentration in each fraction was mea-
sured by the Bradford assay (lower panel, Bradford curve). Activity of the lysosomal enzyme b-hexosaminidase was measured in each
fraction (lower panel, b Hex curve). Fractions were then analyzed by Western blot using antibodies against MHC class II (known to be
present both at the surface and in lysosomes in immature DCs), gp96, and hsc73 (lower panel). gp96 and the 80-kD band generated by
trypsin digestion (see upper panel, LDM 2 or 1 trypsin) are only localized in the noncharged ER/Golgi/plasma membrane fractions,
whereas the 60-kD band generated from hsc73 upon trypsin digestion accumulates in negatively charged endosomo-lysosomal fractions.Théry et al. Protein Composition of Exosomes from Dendritic Cells 609
ruses in D1 cells, as in most laboratory mice strains (Cho
et al., 1995). Gag is a cytosolic protein associated to mem-
branes by its myristoylated NH2 terminus. The possible as-
sociation of MRV gag with endocytic membranes has not
been investigated so far, but budding of other retroviruses,
such as HIV, into MVBs has been observed (Raposo, G.,
unpublished observation). However, morphological EM
analysis failed to reveal any viral particle in our exosome
preparations (G. Raposo, not shown).
The work described here represents the first extensive
analysis of the protein composition of a subendocytic com-
partment. The identification of most major components
gives new critical insights into the function of DC-derived
exosomes. It confirms their endocytic origin and suggests
novel possibilities for their biogenesis, their cellular target-
ing, and their modes of action in vivo. The selective pro-
duction of exosomes by immature DCs suggests that, in
vivo, exosomes are produced in peripheral tissues, and not
in the secondary lymphoid organs, where DCs migrate af-
ter maturation to stimulate T cells. Therefore, exosomes
most likely do not directly activate T lymphocytes, but
rather sensitize other DCs, which have not encountered
antigens themselves for T cell stimulation. Through trans-
fer of MHC–peptide complexes, antigens, or hsp-associ-
ated peptides, exosomes could represent a novel means of
communication between cells of the immune system.
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